PT Kimia Farma (Persero) Tbk

Jakarta Stock Exchange KAEF.JK

PT Kimia Farma (Persero) Tbk Price to Earnings Ratio (P/E) on February 06, 2025: -1.99

PT Kimia Farma (Persero) Tbk Price to Earnings Ratio (P/E) is -1.99 on February 06, 2025, a 40.45% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

PT Kimia Farma (Persero) Tbk 52-week high Price to Earnings Ratio (P/E) is -1.96 on June 20, 2024, which is 1.17% above the current Price to Earnings Ratio (P/E).
PT Kimia Farma (Persero) Tbk 52-week low Price to Earnings Ratio (P/E) is -3.50 on March 22, 2024, which is -76.15% below the current Price to Earnings Ratio (P/E).
PT Kimia Farma (Persero) Tbk average Price to Earnings Ratio (P/E) for the last 52 weeks is -2.52.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Jakarta Stock Exchange: KAEF.JK

PT Kimia Farma (Persero) Tbk

CEO	Mr. David Utama
IPO Date	July 5, 2001
Location	Indonesia
Headquarters	Jl. Veteran No.9
Employees	10,712
Sector	Healthcare
Industries Pharmaceuticals Cleaning Supplies Consumer Packaged Goods Cosmetics Drugstores & Retail Pharmacies Non-Alcoholic Beverages Perfumes & Fragrances Personal Care

Description

PT Kimia Farma (Persero) Tbk produces and sells medicines, herbal medicines, iodine, salts, quinine and their derivative products, and vegetable oils in Indonesia. The company operates through Manufacturing, Distribution, Retail, and Other Services segments. It also manufactures and sells generic, ethical, license and narcotic medicines, and over the counter medicines, health equipment, raw materials, medicines, medical devices, and cosmetics. In addition, the company distributes its products in drug to pharmacies, hospital pharmacy installation, medical center, and drug stores. The company was founded in 1817 and is headquartered in Jakarta, Indonesia.

Key trends

Past 5 years